These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Analysis of non-HLA genomic risk factors in HLA-matched unrelated donor hematopoietic cell transplantation for chronic myeloid leukemia. Pearce KF; Lee SJ; Haagenson M; Petersdorf EW; Norden J; Collin MP; Klein JP; Spellman SR; Lowerson SA; Davies S; Dickinson AM Haematologica; 2012 Jul; 97(7):1014-9. PubMed ID: 22271889 [TBL] [Abstract][Full Text] [Related]
28. Immune recovery in adult patients after myeloablative dual umbilical cord blood, matched sibling, and matched unrelated donor hematopoietic cell transplantation. Kanda J; Chiou LW; Szabolcs P; Sempowski GD; Rizzieri DA; Long GD; Sullivan KM; Gasparetto C; Chute JP; Morris A; McPherson J; Hale J; Livingston JA; Broadwater G; Niedzwiecki D; Chao NJ; Horwitz ME Biol Blood Marrow Transplant; 2012 Nov; 18(11):1664-1676.e1. PubMed ID: 22698485 [TBL] [Abstract][Full Text] [Related]
29. Association between Nondominant Unit Total Nucleated Cell Dose and Engraftment in Myeloablative Double-Unit Cord Blood Transplantation. Purtill D; Stevens CE; Lubin M; Ponce D; Hanash A; Giralt S; Scaradavou A; Young JW; Barker JN Biol Blood Marrow Transplant; 2015 Nov; 21(11):1981-4. PubMed ID: 26211983 [TBL] [Abstract][Full Text] [Related]
30. Allogeneic hematopoietic cell transplantation outcomes in acute myeloid leukemia: similar outcomes regardless of donor type. Warlick ED; Peffault de Latour R; Shanley R; Robin M; Bejanyan N; Xhaard A; Brunstein C; Sicre de Fontbrune F; Ustun C; Weisdorf DJ; Socie G Biol Blood Marrow Transplant; 2015 Feb; 21(2):357-63. PubMed ID: 25452032 [TBL] [Abstract][Full Text] [Related]
31. HLA-C antigen mismatch is associated with worse outcome in unrelated donor peripheral blood stem cell transplantation. Woolfrey A; Klein JP; Haagenson M; Spellman S; Petersdorf E; Oudshoorn M; Gajewski J; Hale GA; Horan J; Battiwalla M; Marino SR; Setterholm M; Ringden O; Hurley C; Flomenberg N; Anasetti C; Fernandez-Vina M; Lee SJ Biol Blood Marrow Transplant; 2011 Jun; 17(6):885-92. PubMed ID: 20870028 [TBL] [Abstract][Full Text] [Related]
32. Effect of T-cell depletion as graft-versus-host disease prophylaxis on engraftment, relapse, and disease-free survival in unrelated marrow transplantation for chronic myelogenous leukemia. Drobyski WR; Ash RC; Casper JT; McAuliffe T; Horowitz MM; Lawton C; Keever C; Baxter-Lowe LA; Camitta B; Garbrecht F Blood; 1994 Apr; 83(7):1980-7. PubMed ID: 8142664 [TBL] [Abstract][Full Text] [Related]
33. Children with acute lymphoblastic leukemia who receive T-cell-depleted HLA mismatched marrow allografts from unrelated donors have an increased incidence of primary graft failure but a similar overall transplant outcome. Green A; Clarke E; Hunt L; Canterbury A; Lankester A; Hale G; Waldmann H; Goodman S; Cornish JM; Marks DI; Steward CG; Oakhill A; Pamphilon DH Blood; 1999 Oct; 94(7):2236-46. PubMed ID: 10498594 [TBL] [Abstract][Full Text] [Related]
34. Improved outcome in HLA-identical sibling hematopoietic stem-cell transplantation for acute myelogenous leukemia predicted by KIR and HLA genotypes. Hsu KC; Keever-Taylor CA; Wilton A; Pinto C; Heller G; Arkun K; O'Reilly RJ; Horowitz MM; Dupont B Blood; 2005 Jun; 105(12):4878-84. PubMed ID: 15731175 [TBL] [Abstract][Full Text] [Related]
35. Factors Associated with Long-Term Risk of Relapse after Unrelated Cord Blood Transplantation in Children with Acute Lymphoblastic Leukemia in Remission. Page KM; Labopin M; Ruggeri A; Michel G; Diaz de Heredia C; O'Brien T; Picardi A; Ayas M; Bittencourt H; Vora AJ; Troy J; Bonfim C; Volt F; Gluckman E; Bader P; Kurtzberg J; Rocha V Biol Blood Marrow Transplant; 2017 Aug; 23(8):1350-1358. PubMed ID: 28438676 [TBL] [Abstract][Full Text] [Related]
36. Improving results of allogeneic hematopoietic cell transplantation for adults with acute lymphoblastic leukemia in first complete remission: an analysis from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation. Giebel S; Labopin M; Socié G; Beelen D; Browne P; Volin L; Kyrcz-Krzemien S; Yakoub-Agha I; Aljurf M; Wu D; Michallet M; Arnold R; Mohty M; Nagler A Haematologica; 2017 Jan; 102(1):139-149. PubMed ID: 27686376 [TBL] [Abstract][Full Text] [Related]
37. TcRαβ-depleted haploidentical transplantation results in adult acute leukemia patients. Kaynar L; Demir K; Turak EE; Öztürk ÇP; Zararsız G; Gönen ZB; Gökahmetoğlu S; Şıvgın S; Eser B; Köker Y; Solmaz M; Ünal A; Çetin M Hematology; 2017 Apr; 22(3):136-144. PubMed ID: 27724812 [TBL] [Abstract][Full Text] [Related]
38. Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype. Aversa F; Tabilio A; Velardi A; Cunningham I; Terenzi A; Falzetti F; Ruggeri L; Barbabietola G; Aristei C; Latini P; Reisner Y; Martelli MF N Engl J Med; 1998 Oct; 339(17):1186-93. PubMed ID: 9780338 [TBL] [Abstract][Full Text] [Related]
39. Unrelated Cord Blood Transplantation for Acute Leukemia Diagnosed in the First Year of Life: Outcomes and Risk Factor Analysis. Ruggeri A; Volt F; Locatelli F; Michel G; Diaz de Heredia C; Abecasis M; Zecca M; Vora A; Yakouben K; O'Brien TA; Giardino S; Cornish J; Rocha V; Peters C; Bader P; Gluckman E; Dalle JH Biol Blood Marrow Transplant; 2017 Jan; 23(1):96-102. PubMed ID: 27777140 [TBL] [Abstract][Full Text] [Related]